Alcohol Use Disorder Treatment Market Analysis

  • Report ID: 3804
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Alcohol Use Disorder Treatment Market Segmentation:

Treatment Type

Based on treatment type, the multidisciplinary treatment segment is expected to garner the highest share of 52% in the alcohol use disorder treatment market by the end of 2035. The segment’s dominance is attributable to the long-term effectiveness of the treatment, including medical detoxification, aversion therapy, and healthy lifestyle habits. In this regard, according to a study by NLM in May 2023, patients who received multidisciplinary treatment demonstrated better adherence, with 91.7% maintaining continued hospital visits when compared to those without such support, highlighting the effectiveness of a multidisciplinary approach. This is evidence for a wider scope, thus positively impacting the segment’s growth.

Disorder Type 

Based on disorder type, the alcohol abuse segment is projected to expand at a considerable rate during the forecast period in the alcohol use disorder treatment market. The segment’s dominance is attributable to the lifestyle changes among the younger population, increased alcohol availability, rising discretionary income, and risks associated with alcohol consumption. For instance, in August 2022, the Grayken Center for Addiction at Boston Medical Center finalized the acquisition of alcohol, other drugs, and health to improve patient care in alcohol abuse. This has encouraged companies to undertake several initiatives to enhance their presence in the AUD market.

Our in-depth analysis of the global market includes the following segments:

Treatment Type

  • Multidisciplinary Treatment
  • Medication
  • Therapy

Disorder Type

  • Alcohol Abuse
  • Alcohol Dependence
  • Alcohol Addiction
  • Alcoholism

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of alcohol use disorder treatment is estimated at USD 1.43 billion.

The global alcohol use disorder treatment market size was more than USD 1.36 billion in 2025 and is anticipated to grow at a CAGR of over 6.1%, reaching USD 2.46 billion revenue by 2035.

North America alcohol use disorder treatment market will hold around 46% share by 2035, driven by the robust healthcare infrastructure and growing demand for AUD treatments.

Key players in the market include Teva Pharmaceutical Industries Ltd., BioCorRx, Inc, Adial Pharmaceuticals, ADDEX Therapeutics, Kinnov Therapeutics, Opiant Pharmaceuticals.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos